Form 4: Vicarious Surgical CEO Sells Shares to Cover Tax Obligations from RSU Vesting
Insider Transaction Report
Vicarious Surgical Inc. CEO Adam David Sachs sold 279 shares of Class A Common Stock at a weighted average price of $7.7996 per share to cover tax withholding obligations related to vested restricted stock units.
Summary
- Adam David Sachs, CEO, Director, and 10% Owner of Vicarious Surgical Inc. (RBOT), reported a transaction on June 23, 2025.
- The transaction involved the sale of 279 shares of Class A Common Stock.
- The shares were sold at a weighted average price of $7.7996 per share, with individual trades ranging from $7.62 to $7.90.
- The sale was conducted to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs) that were granted on November 23, 2021.
- Following this transaction, Adam David Sachs directly beneficially owns 50,444 shares of Class A Common Stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While it's an insider sale, it's explicitly for tax purposes, which is a routine and non-discretionary event, mitigating negative interpretations. The small number of shares also limits its perceived impact.
Negatives
- A reduction in the direct beneficial ownership of Class A Common Stock by a key insider (CEO, Director, 10% Owner), although for tax purposes.
Future Outlook
This document, an SEC Form 4, reports an insider transaction and does not contain any forward-looking statements or guidance regarding the company's future outlook.
Management Comments
- The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.
Industry Context
This SEC Form 4 filing is a routine disclosure of an insider stock transaction and does not provide information related to broader industry trends or competitive landscape within the surgical robotics or medical technology sector.
Stakeholder Impact
- Shareholders: A minor reduction in direct insider ownership, but the reason (tax withholding) suggests no change in management's long-term view of the company.
Key Dates
| Date | Description |
|---|---|
| 11/23/2021 | Date restricted stock units (RSUs) were granted to Adam David Sachs. |
| 06/23/2025 | Date of the reported transaction (sale of Class A Common Stock). |
| 06/24/2025 | Date the Form 4 was signed by Erin Checka, Attorney-in-Fact for Adam David Sachs. |
Keywords
Vicarious Surgical Inc., RBOT, Adam David Sachs, SEC Form 4, Insider Trading, Stock Sale, Restricted Stock Units, Tax Withholding, CEO, Director, 10% Owner
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.